149 related articles for article (PubMed ID: 10617684)
1. Preferential block of late sodium current in the LQT3 DeltaKPQ mutant by the class I(C) antiarrhythmic flecainide.
Nagatomo T; January CT; Makielski JC
Mol Pharmacol; 2000 Jan; 57(1):101-7. PubMed ID: 10617684
[TBL] [Abstract][Full Text] [Related]
2. Selective block of late currents in the DeltaKPQ Na(+) channel mutant by pilsicainide and lidocaine with distinct mechanisms.
Ono K; Kaku T; Makita N; Kitabatake A; Arita M
Mol Pharmacol; 2000 Feb; 57(2):392-400. PubMed ID: 10648650
[TBL] [Abstract][Full Text] [Related]
3. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes.
Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR
Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580
[TBL] [Abstract][Full Text] [Related]
4. Altered Na+ channels promote pause-induced spontaneous diastolic activity in long QT syndrome type 3 myocytes.
Fredj S; Lindegger N; Sampson KJ; Carmeliet P; Kass RS
Circ Res; 2006 Nov; 99(11):1225-32. PubMed ID: 17082480
[TBL] [Abstract][Full Text] [Related]
5. Class Ic antiarrhythmics block human skeletal muscle Na channel during myotonia-like stimulation.
Aoike F; Takahashi MP; Sakoda S
Eur J Pharmacol; 2006 Feb; 532(1-2):24-31. PubMed ID: 16473348
[TBL] [Abstract][Full Text] [Related]
6. State-dependent block of wild-type and inactivation-deficient Na+ channels by flecainide.
Wang GK; Russell C; Wang SY
J Gen Physiol; 2003 Sep; 122(3):365-74. PubMed ID: 12913091
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.
Fredj S; Sampson KJ; Liu H; Kass RS
Br J Pharmacol; 2006 May; 148(1):16-24. PubMed ID: 16520744
[TBL] [Abstract][Full Text] [Related]
8. Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A:DeltaKPQ mutation.
Windle JR; Geletka RC; Moss AJ; Zareba W; Atkins DL
Ann Noninvasive Electrocardiol; 2001 Apr; 6(2):153-8. PubMed ID: 11333173
[TBL] [Abstract][Full Text] [Related]
9. Flecainide sensitivity of a Na channel long QT mutation shows an open-channel blocking mechanism for use-dependent block.
Zhu Y; Kyle JW; Lee PJ
Am J Physiol Heart Circ Physiol; 2006 Jul; 291(1):H29-37. PubMed ID: 16501012
[TBL] [Abstract][Full Text] [Related]
10. Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability.
Blana A; Kaese S; Fortmüller L; Laakmann S; Damke D; van Bragt K; Eckstein J; Piccini I; Kirchhefer U; Nattel S; Breithardt G; Carmeliet P; Carmeliet E; Schotten U; Verheule S; Kirchhof P; Fabritz L
Heart Rhythm; 2010 Dec; 7(12):1862-9. PubMed ID: 20728579
[TBL] [Abstract][Full Text] [Related]
11. The Citrus Flavonoid Hesperetin Has an Inadequate Anti-Arrhythmic Profile in the ΔKPQ Na
Alvarez-Collazo J; López-Requena A; Alvarez JL; Talavera K
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32599724
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic mechanism of the enhanced rate-dependent QT shortening in the R1623Q mutant of the LQT3 syndrome.
Oginosawa Y; Nagatomo T; Abe H; Makita N; Makielski JC; Nakashima Y
Cardiovasc Res; 2005 Jan; 65(1):138-47. PubMed ID: 15621041
[TBL] [Abstract][Full Text] [Related]
13. Channel openings are necessary but not sufficient for use-dependent block of cardiac Na(+) channels by flecainide: evidence from the analysis of disease-linked mutations.
Liu H; Tateyama M; Clancy CE; Abriel H; Kass RS
J Gen Physiol; 2002 Jul; 120(1):39-51. PubMed ID: 12084774
[TBL] [Abstract][Full Text] [Related]
14. Molecular pharmacology of the sodium channel mutation D1790G linked to the long-QT syndrome.
Abriel H; Wehrens XH; Benhorin J; Kerem B; Kass RS
Circulation; 2000 Aug; 102(8):921-5. PubMed ID: 10952963
[TBL] [Abstract][Full Text] [Related]
15. Temperature dependence of early and late currents in human cardiac wild-type and long Q-T DeltaKPQ Na+ channels.
Nagatomo T; Fan Z; Ye B; Tonkovich GS; January CT; Kyle JW; Makielski JC
Am J Physiol; 1998 Dec; 275(6):H2016-24. PubMed ID: 9843800
[TBL] [Abstract][Full Text] [Related]
16. Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique.
Berecki G; Zegers JG; Bhuiyan ZA; Verkerk AO; Wilders R; van Ginneken AC
J Physiol; 2006 Jan; 570(Pt 2):237-50. PubMed ID: 16254012
[TBL] [Abstract][Full Text] [Related]
17. The effects of class Ic antiarrhythmics on tetrodotoxin-resistant Na+ currents in rat sensory neurons.
Osawa Y; Oda A; Iida H; Tanahashi S; Dohi S
Anesth Analg; 2004 Aug; 99(2):464-71, table of contents. PubMed ID: 15271726
[TBL] [Abstract][Full Text] [Related]
18. Unexpected mexiletine responses of a mutant cardiac Na+ channel implicate the selectivity filter as a structural determinant of antiarrhythmic drug access.
Sasaki K; Makita N; Sunami A; Sakurada H; Shirai N; Yokoi H; Kimura A; Tohse N; Hiraoka M; Kitabatake A
Mol Pharmacol; 2004 Aug; 66(2):330-6. PubMed ID: 15266024
[TBL] [Abstract][Full Text] [Related]
19. Rate-dependent QT shortening mechanism for the LQT3 deltaKPQ mutant.
Nagatomo T; January CT; Ye B; Abe H; Nakashima Y; Makielski JC
Cardiovasc Res; 2002 Jun; 54(3):624-9. PubMed ID: 12031708
[TBL] [Abstract][Full Text] [Related]
20. Actions of ATX-II and other gating-modifiers on Na(+) currents in HEK-293 cells expressing WT and DeltaKPQ hNa(V) 1.5 Na(+) channels.
Spencer CI
Toxicon; 2009 Jan; 53(1):78-89. PubMed ID: 18996139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
